Dr. Kathleen Jordan, SVP of Medical Affairs at Tia, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on the coronavirus.
Messenger RNA (mRNA) vaccines have transformed the fight against COVID-19 thanks to the success achieved by Pfizer (NYSE: PFE), BioNTech (NASDAQ: BNTX), and Moderna (NASDAQ: MRNA). In this Motley Fool Live video recorded on April 14, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss which company -- whether one of these well-known players or an under-the-radar biotech -- is poised to be the biggest mRNA winner.
The European Commission exercised its option to buy these doses under an existing agreement signed in February. This move brings the total doses the two companies are supplying to EU members to 600 million. From early on in the race to develop a COVID-19 vaccine, AstraZeneca seemed destined to be the top player in Europe.